These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 34931458)

  • 1. Incidence, predictors of success and outcome of LISA in very preterm infants.
    Balazs G; Balajthy A; Riszter M; Kovacs T; Szabo T; Belteki G; Balla G
    Pediatr Pulmonol; 2022 Jul; 57(7):1751-1759. PubMed ID: 34931458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants.
    Kaniewska U; Gulczyńska E
    Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a respiratory care protocol including less invasive surfactant administration in preterm infants.
    Chan CS; Chiu M; Ariyapadi S; Brown LS; Burchfield P; Simcik V; Garcia K; Mazioniene K; Jaleel MA; Wyckoff MH; Kapadia VS; Kakkilaya V
    Pediatr Res; 2024 May; 95(6):1603-1610. PubMed ID: 38097721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Less invasive surfactant administration versus endotracheal surfactant instillation followed by limited peak pressure ventilation in preterm infants with respiratory distress syndrome in China: study protocol for a randomized controlled trial.
    Zhu J; Bao Y; Du L; Huang H; Lv Q; Jiang Y; Dai Y; Chen Z; Shi J; Shi Y; Yang C; Mei H; Jiang H; Sun Y; Sun X
    Trials; 2020 Jun; 21(1):516. PubMed ID: 32527290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nasal intermittent positive pressure ventilation during less invasive surfactant administration in preterm infants: An open-label randomized controlled study.
    Dani C; Napolitano M; Barone C; Manna A; Nigro G; Scarpelli G; Bonanno E; Gatto S; Cavigioli F; Forcellini C; Petoello E; Beghini R; Ciarcià M; Fusco M; Mosca F; Lavizzari A; Gitto E; Barbuscia L; Betta P; Mattia C; Corvaglia L; Vedovato S; Vento G; Maffei G; Falsaperla R; Lago P; Boni L; Lista G;
    Pediatr Pulmonol; 2024 Apr; 59(4):1006-1014. PubMed ID: 38441525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three-year perinatal outcomes of less invasive beractant administration in preterm infants with respiratory distress syndrome.
    Ramos-Navarro C; Sánchez-Luna M; Zeballos-Sarrato S; González-Pacheco N
    J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2704-2710. PubMed ID: 30526187
    [No Abstract]   [Full Text] [Related]  

  • 7. Cost-saving effect of early less invasive surfactant administration versus continuous positive airway pressure therapy alone for preterm infants with respiratory distress syndrome.
    Federici C; Fornaro G; Roehr CC
    Eur J Hosp Pharm; 2022 Nov; 29(6):346-352. PubMed ID: 33658228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal Preterm Respiratory Care in Ukraine: An Observational Study of Outcomes in Relation to Timing and Methods of Surfactant Treatment.
    Dobryanskyy DO; Menshykova AO; Salabay ZV; Detsyk OY
    Am J Perinatol; 2022 Jun; 39(8):889-896. PubMed ID: 33152767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicentre, randomised trial of preterm infants receiving caffeine and less invasive surfactant administration compared with caffeine and early continuous positive airway pressure (CaLI trial): study protocol.
    Ines F; Hutson S; Coughlin K; Hopper A; Banerji A; Uy C; Finer N; Rich W; Morales A; Steen J; Katheria AC
    BMJ Open; 2021 Jan; 11(1):e038343. PubMed ID: 33483435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Five-year single center experience on surfactant treatment in preterm infants with respiratory distress syndrome: LISA vs INSURE.
    Buyuktiryaki M; Alarcon-Martinez T; Simsek GK; Canpolat FE; Tayman C; Oguz SS; Kutman HGK
    Early Hum Dev; 2019 Aug; 135():32-36. PubMed ID: 31229792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Less invasive surfactant administration versus intubation for surfactant delivery in preterm infants with respiratory distress syndrome: a systematic review and meta-analysis.
    Aldana-Aguirre JC; Pinto M; Featherstone RM; Kumar M
    Arch Dis Child Fetal Neonatal Ed; 2017 Jan; 102(1):F17-F23. PubMed ID: 27852668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimally invasive surfactant therapy failure: risk factors and outcome.
    Janssen LC; Van Der Spil J; van Kaam AH; Dieleman JP; Andriessen P; Onland W; Niemarkt HJ
    Arch Dis Child Fetal Neonatal Ed; 2019 Nov; 104(6):F636-F642. PubMed ID: 31036700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Less invasive surfactant administration via infant feeding tube versus InSurE method in preterm infants: a randomized control trial.
    Anand R; Nangia S; Kumar G; Mohan MV; Dudeja A
    Sci Rep; 2022 Dec; 12(1):21955. PubMed ID: 36535971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome.
    Fujii A; Allen R; Doros G; O'Brien S
    J Perinatol; 2010 Oct; 30(10):671-6. PubMed ID: 20336077
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Administration of Surfactant Using Less Invasive Methods With Outcomes in Extremely Preterm Infants Less Than 27 Weeks of Gestation.
    Härtel C; Herting E; Humberg A; Hanke K; Mehler K; Keller T; Mauer I; Frieauff E; Meyer S; Thome UH; Wieg C; Schmidtke S; Kribs A; Göpel W;
    JAMA Netw Open; 2022 Aug; 5(8):e2225810. PubMed ID: 35943742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of less invasive surfactant administration on cerebral oxygenation in preterm infants.
    Hanke K; Rausch TK; Paul P; Hellwig I; Krämer C; Stichtenoth G; Herz A; Wieg C; König IR; Göpel W; Herting E; Härtel C
    Acta Paediatr; 2020 Feb; 109(2):291-299. PubMed ID: 31310677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Less Invasive Surfactant Administration in Preterm Infants with Respiratory Distress Syndrome.
    Halim A; Shirazi H; Riaz S; Gul SS; Ali W
    J Coll Physicians Surg Pak; 2019 Mar; 29(3):226-330. PubMed ID: 30823947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical impact of less invasive surfactant administration using video laryngoscopy in extremely preterm infants.
    Baczynski M; Deekonda V; Hamilton L; Lindsay B; Ye XY; Jain A
    Pediatr Res; 2023 Mar; 93(4):990-995. PubMed ID: 35854087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Should less invasive surfactant administration (LISA) become routine practice in US neonatal units?
    Kakkilaya V; Gautham KS
    Pediatr Res; 2023 Apr; 93(5):1188-1198. PubMed ID: 35986148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of less-invasive surfactant administration in a Canadian neonatal intensive care unit.
    Bensouda B; St-Hilaire M; Mandel R; Barbier A; Ali N
    Arch Pediatr; 2022 Aug; 29(6):444-447. PubMed ID: 35667998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.